DK171698B1 - 2-amino-4-morpholino-6-propyl-1,3,5-triaziner og farmaceutiske præparater med indhold af sådanne forbindelser - Google Patents

2-amino-4-morpholino-6-propyl-1,3,5-triaziner og farmaceutiske præparater med indhold af sådanne forbindelser Download PDF

Info

Publication number
DK171698B1
DK171698B1 DK398189A DK398189A DK171698B1 DK 171698 B1 DK171698 B1 DK 171698B1 DK 398189 A DK398189 A DK 398189A DK 398189 A DK398189 A DK 398189A DK 171698 B1 DK171698 B1 DK 171698B1
Authority
DK
Denmark
Prior art keywords
propyl
morpholino
group
amino
alkyl
Prior art date
Application number
DK398189A
Other languages
Danish (da)
English (en)
Other versions
DK398189D0 (da
DK398189A (da
Inventor
Eric Cossement
Jean Gobert
Roland Boydens
Jacques Mathieu
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of DK398189D0 publication Critical patent/DK398189D0/da
Publication of DK398189A publication Critical patent/DK398189A/da
Application granted granted Critical
Publication of DK171698B1 publication Critical patent/DK171698B1/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
    • C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
    • C07D251/16—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom
    • C07D251/18—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to only one ring carbon atom with nitrogen atoms directly attached to the two other ring carbon atoms, e.g. guanamines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
    • C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
    • C07D251/08—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Cosmetics (AREA)
DK398189A 1988-08-16 1989-08-14 2-amino-4-morpholino-6-propyl-1,3,5-triaziner og farmaceutiske præparater med indhold af sådanne forbindelser DK171698B1 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888819493A GB8819493D0 (en) 1988-08-16 1988-08-16 2-amino-4-morpholino-6-propyl-1 3 5-triazines
GB8819493 1988-08-16

Publications (3)

Publication Number Publication Date
DK398189D0 DK398189D0 (da) 1989-08-14
DK398189A DK398189A (da) 1990-02-17
DK171698B1 true DK171698B1 (da) 1997-03-24

Family

ID=10642235

Family Applications (1)

Application Number Title Priority Date Filing Date
DK398189A DK171698B1 (da) 1988-08-16 1989-08-14 2-amino-4-morpholino-6-propyl-1,3,5-triaziner og farmaceutiske præparater med indhold af sådanne forbindelser

Country Status (28)

Country Link
US (1) US4956367A (de)
EP (1) EP0356413B1 (de)
JP (1) JPH02108675A (de)
KR (1) KR0136108B1 (de)
AT (1) ATE72241T1 (de)
AU (1) AU614247B2 (de)
CA (1) CA1317944C (de)
CY (1) CY1709A (de)
DE (1) DE68900794D1 (de)
DK (1) DK171698B1 (de)
ES (1) ES2038849T3 (de)
FI (1) FI102065B1 (de)
GB (1) GB8819493D0 (de)
GR (1) GR3004267T3 (de)
HK (1) HK95693A (de)
HU (1) HUT58087A (de)
IE (1) IE61205B1 (de)
IL (1) IL91243A (de)
LT (1) LT3601B (de)
MY (1) MY105008A (de)
NO (1) NO179206C (de)
NZ (1) NZ230290A (de)
PL (2) PL161161B1 (de)
PT (1) PT91438B (de)
RU (3) RU1806142C (de)
SG (1) SG27893G (de)
UA (1) UA11064A (de)
ZA (1) ZA896222B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9024617D0 (en) * 1989-12-05 1991-01-02 Ici Plc Heterocyclic compounds
GB9008818D0 (en) * 1990-04-19 1990-06-13 Ici Plc Amine derivatives
IT1240690B (it) * 1990-04-30 1993-12-17 Ciba Geigy Ag Composti piperdin-triazinici atti all'impiego come stabilizzanti per materiali organici
GB9116039D0 (en) * 1991-07-25 1991-09-11 Ucb Sa Substituted cyclopropylamino-1,3,5-triazines

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549757A (en) * 1968-03-27 1970-12-22 Shell Oil Co Use of 2-morpholino - 4 - amino-6-substituted-s-triazines for inducing depressant effects in animals
JPS4969688A (de) * 1972-11-02 1974-07-05
FR2262512A1 (en) * 1974-03-01 1975-09-26 Synthelabo 2,4,6-Tri-substd. -1,3,5-triazines - with analgesic and psychotropic activity

Also Published As

Publication number Publication date
DK398189D0 (da) 1989-08-14
KR0136108B1 (ko) 1998-04-25
EP0356413A1 (de) 1990-02-28
AU3991789A (en) 1990-04-05
HK95693A (en) 1993-09-24
ZA896222B (en) 1990-05-30
RU1822403C (ru) 1993-06-15
ES2038849T3 (es) 1993-08-01
FI102065B (fi) 1998-10-15
LTIP829A (en) 1995-02-27
KR900003165A (ko) 1990-03-23
US4956367A (en) 1990-09-11
DE68900794D1 (en) 1992-03-12
DK398189A (da) 1990-02-17
NZ230290A (en) 1991-10-25
FI102065B1 (fi) 1998-10-15
PL161161B1 (pl) 1993-05-31
NO179206C (no) 1996-08-28
HUT58087A (en) 1992-01-28
CY1709A (en) 1994-01-14
IL91243A0 (en) 1990-03-19
GR3004267T3 (de) 1993-03-31
NO893279L (no) 1990-02-19
UA11064A (uk) 1996-12-25
ATE72241T1 (de) 1992-02-15
IE892619L (en) 1990-02-16
FI893714A (fi) 1990-02-17
PL161591B1 (pl) 1993-07-30
IL91243A (en) 1995-05-26
NO179206B (no) 1996-05-20
RU1806142C (ru) 1993-03-30
NO893279D0 (no) 1989-08-15
LT3601B (en) 1995-12-27
MY105008A (en) 1994-07-30
PT91438A (pt) 1990-03-08
RU1838312C (ru) 1993-08-30
CA1317944C (en) 1993-05-18
SG27893G (en) 1993-06-25
JPH02108675A (ja) 1990-04-20
IE61205B1 (en) 1994-10-19
PT91438B (pt) 1995-05-04
FI893714A0 (fi) 1989-08-07
GB8819493D0 (en) 1988-09-21
EP0356413B1 (de) 1992-01-29
AU614247B2 (en) 1991-08-22

Similar Documents

Publication Publication Date Title
US4956363A (en) Treatment of cognitive and behavioral disorders associated with aging and with dementia syndromes
EP0335586B1 (de) Piperidin- und Piperazinderivate, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen, die sie enthalten
PL169646B1 (pl) Sposób wytwarzania nowych pochodnych cykIopropyloamino-1,3,5-triazyny PL PL PL PL PL PL PL PL PL
DK171698B1 (da) 2-amino-4-morpholino-6-propyl-1,3,5-triaziner og farmaceutiske præparater med indhold af sådanne forbindelser
EP0136274B1 (de) 1-Piperazinkarboxamid-Derivate, Verfahren zu ihrer Herstellung und ihre Verwendung in pharmazeutischen Präparaten
US5135931A (en) Pyridinylpiperazine derivatives
EP0211928B1 (de) Piperazinkarboxamide mit phenoxyalkyl oder thiophenoxyalkylseitenketten
DK164155B (da) Aminoguanidinderivater og farmaceutisk tolerable salte deraf, fremgangsmaade til fremstilling deraf, laegemidler indeholdende aminoguanidinderivater og fremgangsmaade til fremstilling af disse laegemidler
HU191586B (en) Process for preparing new derivatives of pyridazine and pyrimidine
WO2017066787A1 (en) Compounds, compositions, and methods of making and using the same
US4826866A (en) 3-amino-5-methyl-1H-pyrazole-4-carboxylic acids and esters thereof as anticonvulsants, muscle relaxants and anxiolytics
SK143096A3 (en) Novel hydroximic acid derivatives, pharmaceutical compositions containing them and process for preparing same
US3549757A (en) Use of 2-morpholino - 4 - amino-6-substituted-s-triazines for inducing depressant effects in animals
US5190960A (en) Medicinal oxazolopyridine compounds
HU211635A9 (en) Pharmaceutically useful bicyclolactam derivative
NZ260531A (en) 2-aminopyrazin-5-carboxamide derivatives and pharmaceutical compositions
CS209917B2 (cs) Způsob přípravy (omega-aminoalkoxy) bibanzylů